FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
BD AutoShield Duo hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Becton, Dickinson UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Seven Seas Cod Liver Oil capsules (Seven Seas Ltd) 120 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml syrup (Rosemont Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Broflex 5mg/5ml syrup (Alliance Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elive Cod Liver Oil 294mg capsules (Ennogen Healthcare Ltd) 30 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
BD AutoShield Duo hypodermic insulin needles for pre-filled / reusable pen injectors screw on 5mm/30gauge (Becton, Dickinson UK Ltd) 100 needle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Seven Seas Cod Liver Oil capsules (Seven Seas Ltd) 60 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Seven Seas Cod Liver Oil capsules (Seven Seas Ltd) 500 capsule VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Pfizer Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Pfizer Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Pfizer Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Pfizer Ltd) 5 patch VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (Alliance Healthcare (Distribution) Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Waymade Healthcare Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 25micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 50micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 75micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Fentanyl 100micrograms/hour transdermal patches (Waymade Healthcare Plc) 5 patch VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 30 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xylocaine Topical 4% solution (AstraZeneca) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Approved Prescription Services) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 40 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Approved Prescription Services) 25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) 40 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Unichem Plc) 25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xylocaine Topical 4% solution (AstraZeneca) 30 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (A A H Pharmaceuticals Ltd) 25 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder 5 kg VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (J M Loveridge Plc) 5 kg VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (J M Loveridge Plc) 100 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sodium benzoate powder (J M Loveridge Plc) 500 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ostenil Plus 40mg/2ml injection pre-filled syringes (TRB Chemidica (UK)) (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ostenil Plus 40mg/2ml injection pre-filled syringes (TRB Chemidica (UK)) 1 pre-filled disposable injection (product) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Collagenase clostridium histolyticum 900microgram powder and solvent for solution for injection vials VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Xiapex 0.9mg powder and solvent for solution for injection vials (Pfizer Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Collagenase clostridium histolyticum 900microgram powder and solvent for solution for injection vials 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Xiapex 0.9mg powder and solvent for solution for injection vials (Pfizer Ltd) 1 vial VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 500mg tablets 90 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (A A H Pharmaceuticals Ltd) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Griseofulvin 500mg tablets (Alliance Healthcare (Distribution) Ltd) 90 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Meclozine 12.5mg tablets VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ibuprofen 200mg / Phenylephrine 5mg tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Viviscal Maximum Strength tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Cold & Flu Relief 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ibuprofen 200mg / Phenylephrine 5mg tablets 16 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Generic Viviscal Maximum Strength tablets 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Day & Night Cold & Flu 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sea-Legs 12.5mg tablets (SSL International Plc) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lemsip Max All Night Cold & Flu tablets (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Viviscal Maximum Strength tablets (Lifes2good) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Meclozine 12.5mg tablets 12 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Lemsip Max All Night Cold & Flu tablets (Reckitt Benckiser Healthcare (UK) Ltd) 16 tablet 2 x 8 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Cold & Flu Relief 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 16 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Viviscal Maximum Strength tablets (Lifes2good) 60 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nurofen Day & Night Cold & Flu 200mg/5mg tablets (Reckitt Benckiser Healthcare (UK) Ltd) 16 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sea-Legs 12.5mg tablets (SSL International Plc) 12 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Sovereign Medical Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution 20 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Sovereign Medical Ltd) 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine 4% solution (Special Order) 20 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oral gel sugar free VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Woodward's teething gel (SSL International Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oral gel sugar free 10 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lidocaine hydrochloride 0.5% / Cetylpyridinium chloride 0.025% oromucosal gel sugar free 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bonjela Junior gel (Reckitt Benckiser Healthcare (UK) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bonjela Junior gel (Reckitt Benckiser Healthcare (UK) Ltd) 15 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Woodward's teething gel (SSL International Plc) 10 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CareSens lancets 0.31mm/30gauge (Spirit Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Imported (United States)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
CareSens lancets 0.31mm/30gauge (Spirit Healthcare Ltd) 100 lancet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg/5ml oral solution (Phoenix Healthcare Distribution Ltd) 120 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 10mg tablets (Phoenix Healthcare Distribution Ltd) 100 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Dicycloverine 20mg tablets (Phoenix Healthcare Distribution Ltd) 84 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Elmiron 100mg capsules (Imported (United States)) 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Suxamethonium chloride 100mg/2ml solution for injection pre-filled syringes VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 55 of 86 Next End


This concept is not in any reference sets

Back to Start